Choosing antithrombotics for atrial fibrillation in primary care
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the UK affecting 1.3 million people. AF is particularly common in older people, with one in ten over the age of 75 years affected. The prevalence of AF is projected to increase with improved survival of patients from chronic cardiac d...
Auteurs principaux: | Mustafa, M, Sheppard, JP |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Royal College of General Practictioners
2020
|
Documents similaires
-
Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
par: E V Schlyakhto, et autres
Publié: (2022-01-01) -
Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study
par: Charis Xuan Xie, et autres
Publié: (2022-12-01) -
ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
par: A. Y. Rychkov, et autres
Publié: (2016-01-01) -
Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
par: V. I. Petrov, et autres
Publié: (2019-03-01) -
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
par: E. A. Ushkalova, et autres
Publié: (2017-05-01)